Your browser doesn't support javascript.
loading
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence.
Conforti, Fabio; Pala, Laura; Pagan, Eleonora; Viale, Giuseppe; Bagnardi, Vincenzo; Peruzzotti, Giulia; De Pas, Tommaso; Bianco, Nadia; Graffeo, Rossella; Rocco, Elena Guerini; Vingiani, Andrea; Gelber, Richard D; Coates, Alan S; Colleoni, Marco; Goldhirsch, Aron.
Afiliación
  • Conforti F; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy. fabio.conforti@ieo.it.
  • Pala L; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
  • Pagan E; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
  • Viale G; Department of Pathology, IEO, European Institute of Oncology IRCCS & State University of Milan, Milan, Italy.
  • Bagnardi V; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
  • Peruzzotti G; Division of Data Management, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • De Pas T; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
  • Bianco N; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Graffeo R; Institute of Oncology (IOSI) and Breast Unit (CSSI) of Southern Switzerland, Bellinzona, Switzerland.
  • Rocco EG; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Vingiani A; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Gelber RD; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, and Frontier Science & Technology Research Foundation, Boston, USA.
  • Coates AS; International Breast Cancer Study Group and University of Sydney, Sydney, Australia.
  • Colleoni M; Division of Data Management, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Goldhirsch A; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Breast Cancer Res ; 21(1): 153, 2019 12 30.
Article en En | MEDLINE | ID: mdl-31888717
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Lobular / Antineoplásicos Hormonales Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Lobular / Antineoplásicos Hormonales Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Italia